Abstract
Type 2 diabetes mellitus (T2DM) is a prevalent chronic condition with increasing global incidence, necessitating effective and well-tolerated treatment options. In recent years, the combination of lobeglitazone sulfate and glimepiride has emerged as a promising therapeutic approach. Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and sulphonylurea or who have inadequate glycemic control on a thiazolidinedione alone or a sulphonylurea alone. This review aims to comprehensively evaluate the efficacy and safety of lobeglitazone sulfate + glimepiride tablets in the management of T2DM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
